navigating-trending-supplements 
Quality Matters
MARCH 8, 2024
Navigating “Trending” Supplements Last year, we witnessed growing interest in consumer health and wellness products that were trending on social media. For some products – like dietary supplements – an impulse buy can be dangerous. adults take supplements and 55% are considered regular users.
Pharmacy Is Right For Me
JANUARY 25, 2023
You have to work incredibly hard to figure out how to navigate this complex matrix of stakeholders and still deliver on your plan, and that’s a constant challenge. I believe it’s very important to study the healthcare business and trends in healthcare consumerism.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmD Live
MAY 13, 2024
It is commonly defined as the routine use of five or more medications, encompassing prescription drugs, over-the-counter (OTC) medications, herbals, and supplements. Patient Behavior: Self-medication among the elderly with over-the-counter (OTC) drugs and supplements is prevalent and often occurs without professional guidance.
PharmaState Academy
MARCH 6, 2024
You challenge the team to think creatively and strategically about how to navigate the upcoming months, encouraging them to share ideas and insights. Pattern Recognition: Patterns and trends within the data will be identified to uncover commonalities and differences in trust-building practices across diverse cultural contexts.
The Thyroid Pharmacist
JULY 21, 2022
Please be sure to review the bottom section of this article about lifestyle, medications, and supplements, as there are several other factors which may affect your thyroid test results. When assessing your rT3 results, it is important to watch for trends of your levels going up.
Express Pharma
MAY 15, 2024
To understand opportunities and challenges in the evolving Asia-Pacific healthcare landscape, Bain & Company conducted a survey in Q4 2023 to uncover consumer-centric trends in healthcare consumption. The adoption of wellness trends, however, is more common among the “healthy and wealthy” group.
FDA Law Blog: Biosimilars
DECEMBER 11, 2023
FDA’s 5-year average across all of CDRH is 73 PMAs, PDPs, Panel-Track PMA Supplements; 3,877 510(k) premarket notifications; and 66 de novo submissions per year. [7] FDA’s 5-year average across all of CDRH is 73 PMAs, PDPs, Panel-Track PMA Supplements; 3,877 510(k) premarket notifications; and 66 de novo submissions per year. [7]
Expert insights. Personalized for you.
98 
Let's personalize your content